WELCOME TO THE NILE WEBINAR FOR APRIL 2021! - Immunize Nevada
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
WELCOME TO THE NILE WEBINAR FOR APRIL 2021! Immunize Nevada is a nonprofit 501c3 coalition that is widely recognized as Nevada’s trusted resource for immunization information and community health outreach for all ages. We accomplish this by fostering education and statewide collaboration with a variety of health partners and collaborators. You may view upcoming web trainings at ImmunizeNevada.org/NILE-webinars Thank you for joining us today!
HOUSEKEEPING ITEMS Connectivity Please log back in and we’ll continue Issues where we left off. Locate the Q & A box and type them Have a there. We will address questions Question? throughout the presentation. Nursing/Pharmacy/CHW CEUs: Complete CEU the post-event survey. Certificates will be Claiming emailed within one week of the live presentation. Recording The recorded webinar and slides will be posted & Slides to ImmunizeNevada.org/NILE-webinars.
DISCLAMER Immunize Nevada’s NILE webinars are made possible by the generosity of speakers who donate their time and expertise to benefit the coalition. The expectation and goal is for community partners to gain knowledge on immunization/infectious disease-related topics through a non-branded, unbiased presentation. The opinions expressed are those of today’s presenter(s) and do not necessarily reflect those shared by Immunize Nevada or its partners.
Meningitis B: What You Need to Know To Increase MenB Vaccination Rates in Nevada Presented by: Alicia Stillman, MBA, MPH (Candidate) Patti Wukovits, BSN, RN 4
About Meningitis B Meningococcal meningitis is the most common form of bacterial meningitis in adolescents and young adults. A It is mainly caused by 5 types of meningococcal bacteria - ABCWY. Y B The bacteria can cause: • Bloodstream infection (meningococcemia) that may lead to sepsis • Meningitis (infection of the membranes that surround the brain and spinal cord) W C Source: https://www.cdc.gov/meningococcal/about/causes-transmission.html
About Meningitis B: transmission, symptoms and complications Source: https://www.cdc.gov/meningococcal/about/causes-transmission.html , https://www.cdc.gov/meningococcal/about/symptoms.html It can kill in a matter of hours. 1 in 10 will die. 2 in 10 will face permanent complications, like limb loss or brain damage.
Meningococcal Meningitis Vaccination: It Takes Two! If a person has not received BOTH the MenB and MenACWY vaccines, they are not fully vaccinated against meningococcal meningitis. Routinely Recommended recommended by CDC based by CDC; on shared required by clinical many schools decision- and colleges making Can be given at the same time at age 16 Source: https://www.cdc.gov/vaccines/vpd/mening/public/index.html * Depending on brand
About the Meningitis B vaccines What are Why is a FDA How is the Current the Available Different Approval MenB MenB Vaccine MenB Vaccine Needed Details Vaccine Uptake Vaccines? for MenB? Administered? Rates Trumenba: Serogroup B Approved by First dose between 78.2% of Oct. 2014, Pfizer requires a different the FDA for 17-year-olds have and a separate 16-23 use in those NOT received ≥1 vaccine because of Bexsero: the way it attacks 10-25 2nd dose must be dose of MenB Jan. 2015, GSK the bacterium. completed within: Yet only 11.1% of Trumenba: 6 months of 1st 17-year-olds have They are not dose NOT received ≥1 interchangeable. dose of MenACWY Bexsero: at least 1 month of 1st dose Sources: Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR. 2019. Meningococcal disease among college-aged young adults: 2014-2016. Pediatrics 143:e20182130. doi:10.1542/peds.2018-2130; https://www.cdc.gov/vaccines/vpd/mening/hcp/administering-vaccine.html
In Nevada… The MenACWY vaccine is required for all incoming freshman
Key Factors Affecting MenB Vaccination Rates In The United States 13
1. ACIP Guidelines Given that it is a newer vaccine, at the time of Why does the CDC ACIP’s review of the MenB vaccine in 2015, there was not enough evidence on: advise that 11-12 yr. olds should receive the • Duration of protection • Effects on carriage MenACWY vaccine and • Effects on herd immunity • Strain coverage 16-23 yr. olds may In addition, the following factors have also receive the Men B been cited: vaccine? • Lower incidence of disease • High cost of routine vaccination Source: https://pediatrics.aappublications.org/content/139/5/e20163484
2. Inconsistent Understanding of ACIP Recommendations Among Providers Provider Perception of ACIP Recommendations (%) Q. What do you see as 60 56 the difference between ACIP recommendations 50 for the MenACWY 40 Nearly 50% of providers were not vaccine and the MenB aware of the correct ACIP vaccine? 30 25 recommendation for the MenB vaccine. 20 Correct response: 10 8 7 MenACWY is routinely 3 recommended; MenB is 0 subject to shared clinical MenACWY MenACWY vaccine is routinely vaccine is more MenACWY is recommended; Other Uncertain of difference decision making recommended; strongly MenB is not MenB vaccine is recommended (SCDM). subject to SCDM than the MenB vaccine (n = 524) Source: https://meningitisbactionproject.org/provider-survey
3. Many Physicians Are Not Talking To Their Patients About the MenB Vaccine According to a study published in Pediatrics in August 2018, among 900 doctors surveyed: 49% of pediatricians 69% of family physicians Did not discuss the MenB vaccine during routine visits for 16-18-year-olds. Source: Allison Kempe, Mandy A. Allison, Jessica R. MacNeil, Sean T. O’Leary, Lori A. Crane, Brenda L. Beaty, Laura P. Hurley, Michaela Brtnikova, Megan C. Lindley, Alison P. Albert. Adoption of Serogroup B Meningococcal Vaccine Recommendations. Pediatrics Aug 2018, http://pediatrics.aappublications.org/content/early/2018/08/16/peds.2018-0344..info
4. Lack of School or College Requirements A school/college not requiring the Meningitis B vaccine was the most frequent reason why healthcare providers did not discuss the vaccine with their 16-23-year-old patients, and also the main reason that parents declined the MenB vaccine. Top 5 Reasons Why Providers Didn't Discuss Top 5 Reasons Why Patients (and/or their MenB Vaccine (%) parents) Declined MenB Vaccine (%) Patient not high-risk Cost 19 9 Patient not going to college MenB is Rare 19 17 Time Constraints Side Effects 25 19 MenB ACIP recommendation not Never Heard of MenB as strong as MenACWY 25 25 Not required by college Not Required by College 32 57 Top 5 reasons included in graphs (n = 170) Source: https://meningitisbactionproject.org/provider-survey 54
We only know of 42 schools currently requiring Meningitis B vaccination. COLLEGES & UNIVERSITIES CURRENTLY REQUIRING MENB VACCINATION California Michigan California Polytechnic State Aquinas College University Calvin University San Diego State University Oakland University Gallaudet University New Hampshire Delaware New England College Delaware State University Rivier University Florida New York Florida Agricultural And Canisius College Mechanical University D'Youville College Daemen College Georgia Le Moyne College Morehouse College SUNY Empire State College Iowa Ohio Grinnell College University of Rio Grande Morningside College St. Ambrose University Pennsylvania Bucknell University Idaho California University of The College of Idaho Pennsylvania Gettysburg College Indiana Lehigh University Ball State University Pennsylvania College of Butler University Technology Earlham College Villanova University Indiana State University Marian University South Carolina Indianapolis Dakota Wesleyan University Key Purdue University South Carolina State Purdue University, University (PURPLE B) schools requiring MenB Northwest University of Evansville Virginia vaccination Rose-Hulman Institute of Shenandoah University Technology (RED !) schools with past MenB St. Mary of the Woods case(s) College Valparaiso University (ORANGE DOT) schools recommending MenB vaccination 18
5. Care-Seeking Behavior Barriers Provider Level Patient Level • Not always followed as closely • Inconvenience by pediatricians • Fear of needles • Transition between pediatrician > family practitioner • Too many shots! • Poor access to childhood immunization records Sources: https://www.sciencedirect.com/science/article/pii/S1198743X14601725 https://pediatrics.aappublications.org/content/139/3/e20164186#sec-8 19
Impact 80% 70% 100% 78% 5x of parents didn’t of all meningococcal of college of 16-18-year-olds more likely in know about the cases in the US are outbreaks since have NOT received college students Meningitis B among 16-23-year- 2011 are caused by at least one dose of (than non-college vaccine (according olds are MenB MenB the MenB vaccine students) to a recent study) Sources: Basta NE, Becker AB, Li Q, Nederhoff D. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens. Vaccine. 2019 Jan 21;37(4):670-676 Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2016. Available at: https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf. Accessed September 19, 2019. Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College — Rhode Island, 2015, Morbidity and Mortality Weekly Report, US Department of Health and Human Services/Centers for Disease Control and Prevention, June 12, 2015 / 64(22). . Outbreak of Serogroup B Meningococcal Disease at a University — California, 2016, Morbidity and Mortality Weekly Report, US Department of Health and Human Services/Centers for Disease Control and Prevention, May 27, 2016, 65 (20) Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018. Vol. 68, No. 33, 23 August 2019. Epidemiology of meningococcal disease among college students – United States, 2014-2016https://stacks.cdc.gov/view/cdc/59918 Gary S Marshall Gary S, Amanda F Dempsey, Amit Srivastava, Raul E Isturiz, US College Students Are at Increased Risk for Serogroup B Meningococcal Disease, Journal of the Pediatric Infectious Diseases Society. piz024. Elam-Evans LD, Yankey D, Singleton JA, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:1109–1116. DOI: http://dx.doi.org/10.15585/mmwr.mm6933a1
Strategies To Improve Awareness And Uptake Of Vaccinations Among Adolescents 21
Co-Create Solutions • Work with adolescents to design strategies and materials • Go beyond insights: It’s about integration! • Know how to execute against their ideas > include them in implementation • Use reputable influencers • Example: Meningitis B educational curriculum for college peer health educators 22
Effective Messaging: Empowerment vs. Scare Tactics “That • Fear appeals can be effective when people 1) feel susceptible to the could health problem and 2) confident in their ability to take action to prevent it (works best for one-time appeals) never • But adolescents feel invincible! happen to Personal stories and concrete steps to avoid the problem can help me!” • Position vaccination as a way to take charge of your health 23
Educate Providers on the Importance of Vaccination Conversations with Adolescents • Providers need education too! • Balance clinical vs. psychological messaging in conversation • Consistency is key: providers have a responsibility to give them the tools to make an informed decision • Talk to both the parent and the adolescent 24
Policies Individual Moving from Knowledge to Action Takes Organi- Community zations A Village Providers 25
The Meningitis B Action Project was created to help close the Meningitis B awareness and vaccination gaps.
What is the Meningitis B Action Project? The project aims to: 1. Empower young adults with information to talk to their healthcare provider about Meningitis B and the vaccine that can help prevent it 2. Encourage healthcare providers to discuss Meningitis B and the MenB vaccine with their patients (and their parents) 3. Increase awareness of Meningitis B on high school, college and university campuses 4. Engage policymakers to facilitate broader access to the Meningitis B Awareness Day House of Representatives Resolution Reading Meningitis B vaccine April 24, 2018 – World Meningitis Day
Our key message: simplicity is key 2 meningitis vaccines are necessary to help protect against meningococcal disease. More have received the MenACWY vaccine. Can be given at the Few have received the same time at MenB vaccine. age 16
Resources to support and amplify your awareness and education efforts Posters Educational resources for: Students Healthcare Professionals Brochures Parents Reminder One Pager for HCPs Local meetings, speaking Tear off Appt. Reminder Pads for Doctor’s engagements, webinars Offices etc. We are eager to share our stories to help you spread this important message. Available for download on Magnets for MeningitisBActionProject.org Sharable Social Doctor’s Offices Media Graphics and Students Videos
How Can You Help? Please help us ensure that no other young life is unnecessarily lost to Meningitis B. Learn more at MeningitisBActionProject.org Talk to your friends, family, community, patients etc. about Meningitis B and the MenB vaccine Distribute our educational materials in clinics, hospitals, offices, colleges Invite us to speak at local events Follow us on Facebook, Twitter and Instagram for more opportunities to get involved
Our Supporters Questions? Contact us at info@meningitisbactionproject.org
LAST MINUTE QUESTIONS & HOUSEKEEPING ITEMS REVIEW Locate the Q & A box and type them Have a there. We will address as many questions Question? as we can today. Nursing/Pharmacy/CHW CEUs: Complete CEU the post-event survey. Certificates will be Claiming emailed within one week of the live presentation. Recording The recorded webinar and slides will be & Slides posted to ImmunizeNevada.org/nile-webinars.
You can also read